Global Pharmaceutical Filtration Market By Product (Membrane filters, Prefilters & depth media, Single-use systems, Cartridges & capsules, Filter holders, Filtration accessories and Other Product Types), By Technique (Microfiltration, Ultrafiltration, Crossflow filtration, Nano filtration and Other Applications), By Application (Final product processing, Raw material filtration, Cell separation, Water purification and Air purification) By Scale of Operation (Manufacturing scale, Pilot-scale, Research & development scale) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Pharmaceutical Filtration Market Overview:

The 2021 global market for pharmaceutical filtration market was worth USD 27,079.69 million with a CAGR value of 14.6%.

This market is expected to experience lucrative growth over the forecast period. Growth is expected to be triggered by a growing emphasis on biologics, and their development for various diseases.

Global Pharmaceutical Filtration Market Scope:

Product Analysis

The largest market share was held by membrane filters in the product category in 2021. This is due to their versatility in many applications, including ultrafiltration, Nanofiltration, and microfiltration. These membrane filters are widely used in many applications and are expected to continue to grow market share over the forecast period. Because of the rapid development of biologics and drugs, the membrane filter segment will see the highest CAGR growth during the study period. To gain the maximum market share, these companies are entering into partnerships and collaborations. Novartis and Xencor Inc. partnered in a strategic partnership that saw Novartis receive the rights to develop bispecific T-cell-engaging antibodies for the treatment of acute myeloid leukemia (AML) and B-cell malignancies.

The use of membrane filters is widespread in the development and manufacture of processes, including sterile filtering and end-stage processes. The forecast period will see a substantial CAGR in the single-use system segment. These systems offer several benefits, including reduced contamination risk, minimal operation time, and ease of use. The demand for single-use systems will rise in the future. They are compact and require less space in factory environments. The Allegro MVP Single-Use System, developed by Pall Corporation, can be used for sterile filtration and bioburden test, as well as depth filtration and buffer preparation.

Technique Analysis

Microfiltration was the highest-generating revenue segment in 2021. This segment is driven by product advancement. Merck KGaA released a Viresolve Pro Shield H, a product that is specifically developed to eliminate parvoviruses in therapeutic protein feed streams. This method is widely used by manufacturers to separate large particles from a liquid feed stream, including yeast. Due to the wide range of applications for ultrafiltration in protein purification and vaccines as well as antibody processes, it is projected that this segment will grow at a profitable rate.

Nanofiber technology innovations are expected to lead to a significant increase in growth rates for the nanofiltration techniques segment during the forecast period. The next-generation nonwoven filter media is nanofibers. They offer unique properties, such as high interconnectivity and the potential to integrate on a small scale. Crossflow filtration has another advantage: it is easy to use, can be used for continuous separation, and is easily flushed away. Sartorius Stedim Biotech released a revolutionary ultrafilter Sartocon Slice 50. This new crossflow filter system was created for various biotech applications, such as membrane screening and process development in small volumes.

Application Analysis

The largest share of final product processing in 2021 was due to its widespread use in active pharmaceutical ingredient processing and vaccine processing. The highest projected CAGR for final product processing is during the forecast period.

Technology advancements such as nanofiber and cross-flow filtering, along with ultrafiltration technology, have led to the adoption of new filters for product processing. This is expected to boost growth. Market growth is also fueled by the increasing use of therapeutic proteins and biologics.

Cell separation plays an important role in many applications, such as the production of monoclonal antibodies, vaccines, and therapeutic proteins to name but a few. For cell separation purposes, depth filtration and microfiltration are often used. These products are expected to be popular in the U.S., U.K, Japan, India, and China. Market growth is aided by the presence of top healthcare companies and advanced products, as well as a well-developed infrastructure for healthcare in these countries.

The market for air filtration is expected to grow at a rapid pace during the study period. It is an essential process for all pharmaceutical and biopharmaceutical businesses. Manufacturers use a variety of advanced products for air purification, such as capsules and cartridges. The broad chemical compatibility provided by Steridyne PVDF Membrane Filter makes it ideal for filtering aggressive process gases like fermentation air, sterile tanks venting, and compressed air and gases.

The scale of Operation Analysis:

The scale of pharmaceutical filtration operations is divided into pilot scale, manufacturing scale, and R&D. Due to increased production of biopharmaceuticals and generic drugs as well as vaccines that are used in various diseases, the manufacturing scale of operations held the highest market share.

Major pharmaceutical companies invest heavily in the production and distribution of therapeutic proteins and biologics, which has created an increased demand for accessories and filtration products. These products are in high demand due to the development of healthcare infrastructure in emerging countries such as Brazil, South Africa, and China as well as rising demand for innovative therapeutics. The pharmaceutical manufacturing process will be influenced by the focus on developing novel drugs and biological products, as well as the availability of advanced technology.

Due to rising investments in R&D and new technology, the research and development segment will see a significant CAGR during the forecast period.

Key Market Segments:

By Product

• Membrane filters
  • MCE membrane filters
  • Coated cellulose acetate membrane filters
  • PTFE membrane filters
  • Nylon membrane filters
  • PVDF membrane filters
  • Other membrane filters
• Prefilters & depth media
  • Glass fiber filters
  • PTFE fiber filters
• Single-use systems
• Cartridges & capsules
• Filter holders
• Filtration accessories
• Others

By Technique

• Microfiltration
• Ultrafiltration
• Crossflow filtration
• Nanofiltration
• Others

By Application

• Final product processing
  • Active pharmaceutical ingredient filtration
  • Sterile filtration
  • Protein purification
  • Vaccines and antibody processing
  • Formulation and filling solutions
  • Viral clearance
• Raw material filtration
  • Media buffer
  • Pre-filtration
  • Bioburden testing
• Cell separation
• Water purification
• Air purification

By Scale of Operation

• Manufacturing scale
• Pilot-scale
• Research & development scale

Market Dynamics:

One reason for the rapid growth of the pharmaceutical sector is the increase in chronic diseases. The demand for therapeutic drugs to treat chronic diseases such as asthma, COPD (cancer), diabetes, COPD, COPD, and cancer is high. Additionally, the production of novel biologics is highly regulated and requires zero contamination. Advanced filtration products are also required for the manufacture of biologics and drugs.

The growth can also be attributed to an increase in investment in the research and development of biologics. The rapid adoption of innovative treatments such as monoclonal antibody vaccines, therapeutic proteins, and vaccines has led to an increase in biotechnology and pharmaceutical companies that use filtration systems (e.g. cartridges and capsules).

Many companies are also investing heavily in manufacturing facilities around the globe. AbbVie Inc. spent USD 320million to build a new facility in Singapore in October 2021 for the production of small-molecule APIs and biologics. Accordingly, there is a projected increase in demand for advanced products due to the growth of biopharmaceutical businesses.

This has led to the growing adoption of pharmaceutical filtration systems by the industry. Market players are always engaged in R&D in order to improve their product portfolios and develop novel technologies to sterilize the media and constituents. AstraZeneca was a top healthcare company and invested approximately USD 5,890 million in R&D.

Regional Analysis:

Large pharmaceutical and biopharmaceutical corporations such as Merck KGaA and Hoffmann-La Roche Ltd., in the North American region, contributed the most to this region’s share. The region’s market has grown because of its well-developed healthcare infrastructure, and easy access to high-quality products.
Because of its advanced healthcare infrastructure and availability of high-tech products, the European region is another major market. This region is expected to see an increase in demand for biopharmaceuticals. The region is home to many European-based market leaders like Sartorius Stedim Biotech S.A. and Merck KGaA. The development of new devices and systems allows Europe to grab a significant share.

Due to the untapped potential of the market, the Asia Pacific pharmaceutical filter market will experience the highest CAGR over the forecast period. This region has seen tremendous growth due to the proliferation of biopharmaceutical and pharmaceutical companies. These companies are able to benefit from the increased market growth due to their heavy investments in CMOs (Contract Manufacturer Organizations) as well as CROs (Contract Research Organizations). The market’s growth is largely due to the development of healthcare infrastructure and large genome pools.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

The major players have a broad product range and are always expanding their portfolios. Most of these players have a wide-ranging distribution network. Due to the strong distribution channels and large product portfolios, vendors are facing intense competition. This has created high pressure on pricing strategies, which can impact the vendors’ profit margins.

In order to increase their market share, top players participate in collaborations, new product developments, mergers &acquisitions, and regional expansions. The companies can increase their product portfolio and geographic reach through acquisitions. Some key players are:

Маrkеt Кеу Рlауеrѕ:

• Eaton Corporation Plc
• Merck KGaA
• Amazon Filters Ltd
• GE Healthcare
• Parker Hannifin Corporation
• Sartorius Stedim Biotech S.A
• Graver Technologies LLC
• Danaher Corporation Inc
• Other Key Players

For the Global Pharmaceutical Filtration Market research study, the following years have been considered to estimate the market size: